These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Inhibition of human beta-tryptase by Bowman-Birk inhibitor derived peptides: creation of a new tri-functional inhibitor. Scarpi D, McBride JD, Leatherbarrow RJ. Bioorg Med Chem; 2004 Dec 01; 12(23):6045-52. PubMed ID: 15519150 [Abstract] [Full Text] [Related]
15. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP). Haffner CD, Diaz CJ, Miller AB, Reid RA, Madauss KP, Hassell A, Hanlon MH, Porter DJ, Becherer JD, Carter LH. Bioorg Med Chem Lett; 2008 Aug 01; 18(15):4360-3. PubMed ID: 18606544 [Abstract] [Full Text] [Related]
16. Novel, potent, selective, and orally bioavailable human betaII-tryptase inhibitors. Sperandio D, Tai VW, Lohman J, Hirschbein B, Mendonca R, Lee CS, Spencer JR, Janc J, Nguyen M, Beltman J, Sprengeler P, Scheerens H, Lin T, Liu L, Gadre A, Kellogg A, Green MJ, McGrath ME. Bioorg Med Chem Lett; 2006 Aug 01; 16(15):4085-9. PubMed ID: 16725321 [Abstract] [Full Text] [Related]
17. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase. Wong T, Groutas CS, Mohan S, Lai Z, Alliston KR, Vu N, Schechter NM, Groutas WC. Arch Biochem Biophys; 2005 Apr 01; 436(1):1-7. PubMed ID: 15752703 [Abstract] [Full Text] [Related]
18. Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease. Parsy C, Alexandre FR, Brandt G, Caillet C, Cappelle S, Chaves D, Convard T, Derock M, Gloux D, Griffon Y, Lallos L, Leroy F, Liuzzi M, Loi AG, Moulat L, Musiu C, Rahali H, Roques V, Seifer M, Standring D, Surleraux D. Bioorg Med Chem Lett; 2014 Sep 15; 24(18):4444-4449. PubMed ID: 25155387 [Abstract] [Full Text] [Related]